T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
MongoDB
MDB
$38B
| $25.6M | ﹤0.01% |
+861,352
| New | +$25.2M |
|
1102
Dover
DOV
$27.8B
| $25.6M | ﹤0.01% |
313,363
-36,273
| -10% | -$2.81M |
|
1103
Kaiser Aluminum
KALU
$2.99B
| $25.5M | ﹤0.01% |
239,056
-104,805
| -30% | -$10.5M |
|
1104
NetApp
NTAP
$40.2B
| $25.2M | ﹤0.01% |
456,003
-22,700
| -5% | -$1.14M |
|
1105
Commault Systems
CVLT
$6.26B
| $25.1M | ﹤0.01% |
478,911
-7,815
| -2% | -$432K |
|
|
MGP
1106
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $25.1M | ﹤0.01% |
862,171
+30,740
| +4% | +$901K |
|
|
AGN.PRA
1107
DELISTED
Allergan plc
AGN.PRA
| $25.1M | ﹤0.01% |
42,876
-31,128
| -42% | -$20.1M |
|
|
HZN
1108
DELISTED
Horizon Global Corporation
HZN
| $25M | ﹤0.01% |
1,786,612
-600,018
| -25% | -$9.1M |
|
|
DNB
1109
DELISTED
Dun & Bradstreet
DNB
| $25M | ﹤0.01% |
211,033
-2,983
| -1% | -$354K |
|
1110
CALL
J.M. Smucker
SJM
$12.9B
| $24.8M | ﹤0.01% |
200,000
| – | – |
|
1111
Oil-Dri
ODC
$1.27B
| $24.8M | ﹤0.01% |
1,193,068
-44,200
| -4% | -$970K |
|
|
1112
J.M. Smucker
SJM
$12.9B
| $24.7M | ﹤0.01% |
199,199
-23,565
| -11% | -$2.62M |
|
|
BIG
1113
DELISTED
Big Lots, Inc.
BIG
| $24.6M | ﹤0.01% |
437,312
-11,075
| -2% | -$601K |
|
1114
AdvanSix
ASIX
$446M
| $24.5M | ﹤0.01% |
583,044
+34,034
| +6% | +$1.46M |
|
1115
Lincoln Electric
LECO
$15.5B
| $24.5M | ﹤0.01% |
267,238
+15,665
| +6% | +$1.43M |
|
1116
Acadia Pharmaceuticals
ACAD
$4.89B
| $24.5M | ﹤0.01% |
812,627
-1,273,970
| -61% | -$40.7M |
|
1117
Delek US
DK
$4.18B
| $24.4M | ﹤0.01% |
699,005
-394,094
| -36% | -$11.6M |
|
1118
Ameren
AEE
$30.2B
| $24.1M | ﹤0.01% |
408,990
-31,423
| -7% | -$1.93M |
|
|
MZTI
1119
The Marzetti Company
MZTI
$3.22B
| $24.1M | ﹤0.01% |
186,666
-387
| -0.2% | -$48.8K |
|
|
NEX
1120
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $24M | ﹤0.01% |
1,262,228
+8,870
| +0.7% | +$139K |
|
|
ARRS
1121
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $24M | ﹤0.01% |
933,476
-215,006
| -19% | -$6.04M |
|
1122
Genuine Parts
GPC
$18.7B
| $24M | ﹤0.01% |
252,132
-19,000
| -7% | -$1.74M |
|
|
FCE.A
1123
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $23.9M | ﹤0.01% |
992,343
-21,520
| -2% | -$533K |
|
|
SYNH
1124
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $23.9M | ﹤0.01% |
548,249
-17,554
| -3% | -$820K |
|
1125
First Bancorp
FBNC
$2.74B
| $23.9M | ﹤0.01% |
676,101
+105,950
| +19% | +$3.84M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.